Potential Health Problems Linked to Ozempic, Wegovy, and Other Weight Loss Drugs Recent studies and reports highlight that Ozempic, Wegovy, and other GLP-1 receptor agonist drugs are associated with serious health risks, including stomach paralysis, also known as gastroparesis, as well as other gastrointestinal issues
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double-blind, randomized, placebo-controlled trial argeting negative symptoms
Hypoglycaemia: Risk is low when used without insulin or sulphonylureas, but men with type 2 diabetes on combination therapy should monitor blood glucose carefully
Semaglutide was FDA-approved in 2017 for type 2 diabetes under the brand name Ozempic and was later found to be beneficial for weight loss, achieving about 15% weight loss sustainably 1
Returning to the classroom after a concussion can be just as tricky as returning to sports, so its best to take it slow and be guided by their symptoms
The treatment is administered as a once-daily injection, compared with the once-weekly dosing of semaglutide